CIP
INFI

Chartwell Investment Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Chartwell Investment Partners’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-335,185
Closed -$5.84M – 374
2013
Q3 		$5.84M Sell
335,185
-14,965
-4% -$287K 0.13% 233
2013
Q2 		$5.67M Buy
+350,150
New +$10.8M 0.14% 234

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Chartwell Investment Partners's INFI Position: Q4 2013 in Review

Chartwell Investment Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2013, closing a stake of 335,185 shares — an estimated $5.84M sold.

Chartwell Investment Partners first reported a position in INFI in Q2 2013 and held it in 2 quarters. The position peaked at $5.84M in Q3 2013. 104 funds tracked by Wall St. Rank hold INFI as of Q4 2013.

  • Chartwell Investment Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Chartwell Investment Partners sold 335,185 Infinity Pharmaceuticals, Inc. shares in Q4 2013, an estimated $5.84M.
  • Chartwell Investment Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 2 quarters.
  • Chartwell Investment Partners's Infinity Pharmaceuticals, Inc. position peaked at $5.84M in Q3 2013.
  • 104 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2013.

Based on Chartwell Investment Partners's 13F filing for Q4 2013, filed 10 Feb 2014.